Condition
Gastric (Cardia, Body) Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Gastric (Cardia, Body) Cancer clinical trials that are recruiting, at sites in 8 countries (most in Netherlands (2), United States (1), China (1)). By phase: Phase 3 (1), Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 8Countries
Newest Gastric (Cardia, Body) Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How the CES1 liver enzyme affects capecitabine levels in people with colorectal, gastric, or esophageal cancer | — | Rotterdam | Recruiting | Aug 11, 2025 |
| Best time for minimally invasive local treatment after first-line systemic therapy for limited (oligo) esophageal or stomach cancer | Phase 2 | Amsterdam and 4 other locations | Recruiting | Jun 2, 2025 |
| Quality of life after Billroth II or Roux-en-Y for distal gastric cancer | Phase 3 | Paris | Recruiting | Jan 10, 2025 |
| Evaluating pain management methods for minimally invasive cancer surgery | — | Pittsburgh, Pennsylvania | Recruiting | Dec 13, 2024 |
| Examining the relationship between Sintilimab levels and treatment outcomes in advanced gastric cancer patients | — | Nanjing, Jiangsu | Recruiting | Nov 25, 2024 |
| Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer | Phase 2/3 | Vilnius and 1 other locations | Recruiting | Sep 8, 2023 |
All recruiting trials (6)
-
How the CES1 liver enzyme affects capecitabine levels in people with colorectal, gastric, or esophageal cancer
This project will see if differences in the CES1 enzyme change how capecitabine is processed and whether that affects side effects like hand‑foot syndrome in adults starting capecitabine with oxaliplatin for colorectal, gastric, or esophageal cancer.
-
Best time for minimally invasive local treatment after first-line systemic therapy for limited (oligo) esophageal or stomach cancer
This trial will test whether giving local treatment (surgery or radiation) earlier or later after first-line systemic therapy works better for people whose esophageal or stomach cancer has spread to only a few sites.
-
Quality of life after Billroth II or Roux-en-Y for distal gastric cancer
This study tests whether Billroth II or Roux-en-Y reconstruction after distal gastrectomy affects quality of life in adults with distal gastric cancer.
-
Evaluating pain management methods for minimally invasive cancer surgery
This study is testing which pain management method works best for people undergoing minimally invasive cancer surgery by comparing three different approaches.
-
Examining the relationship between Sintilimab levels and treatment outcomes in advanced gastric cancer patients
This study is testing how the levels of Sintilimab in the blood affect treatment results and side effects for people with advanced gastric cancer.
-
Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer
This study is testing two different chemotherapy plans for people with advanced stomach cancer to see which one helps them better tolerate treatment and successfully have surgery.
Related topics
Quick answers
How many Gastric (Cardia, Body) Cancer clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Netherlands (2 trials), United States (1 trial), China (1 trial), France (1 trial), Norway (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.